A “groundbreaking” £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure.Read More

You might also be interested in reading Arbitrum In Freefall, Dips Below $2 As Experts Analyze Recovery Timelines.